Clinical protection study of pseudorabies vaccine (AUSKIPRA® GN bartha k61 strain) in piglets infected with new Chinese PRV variant
Clinical protection study of pseudorabies vaccine (AUSKIPRA® GN bartha k61 strain) in piglets infected with new Chinese PRV variant
Since 2011, several pseudorabies (PR) outbreaks have damaged Chinese swine industry. The purpose of this experiment is to test the efficacy of pseudorabies vaccine AUSKIPRA® GN (HIPRA) against new pseudorabies virus variant (AH02).
Об этой статье
Похожие продукты
The contents of this page are country specific and aimed specifically at prescribing veterinarians.
This product is not available in {{ preferredCountry.title }}.
You will be redirected to our global site. Click on continue to visit our global site (available in English).
Confirm that you are a veterinary professional:
- I am a veterinarian (otherwise please contact a veterinary professional)
Select your country:
Country
{{countrySelect.title}}
- Global (available in English)
- {{country.title}}
